Language : 中文
黄秋

Paper Publications

A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia

Hits:

Journal:ALZHEIMERS RESEARCH & THERAPY

ISSN No.:17589193

Translation or Not:no

Date of Publication:2021-03-01

Indexed by:期刊论文

Date of Publication:2021-03-01

Recommend this Article

 沪ICP备05052060 版权所有©上海交通大学

Click: